Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Yadgarova Sitora Qahramonovna

8 ta ish

Lecturer in Pharmaceutical Deontology Department of General Subjects Asia International University Bukhara, Uzbekistan

  1. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: HISTORICAL AND THEORETICAL PERSPECTIVES

    Yadgarova Sitora Qahramonovna

    BoshqaOpen MIND20260 iqtibos
    ABI

  2. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: HISTORICAL AND THEORETICAL PERSPECTIVES

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  3. MEDICAL WORKERS' RIGHTS IN PHARMACEUTICAL PRACTICE: LEGAL, ETHICAL AND REGULATORY FRAMEWORKS

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  4. MEDICAL WORKERS' RIGHTS IN PHARMACEUTICAL PRACTICE: LEGAL, ETHICAL AND REGULATORY FRAMEWORKS

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  5. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  6. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  7. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  8. THE EMERGENCE AND DEVELOPMENT OF PHARMACEUTICAL DEONTOLOGY: COUNTERFEIT MEDICINES: A GLOBAL PUBLIC HEALTH THREAT

    Yadgarova Sitora Qahramonovna

    BoshqaZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI